Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012-2017

被引:20
作者
Lee, Hyukmin [1 ]
Suh, Young Hee [1 ]
Lee, Sunhwa [2 ]
Kim, Yong-Kyun [3 ]
Han, Mi-Soon [4 ]
Bae, Hye Gyung [5 ]
Unemo, Magnus [6 ]
Lee, Kyungwon [1 ]
机构
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Seegene Med Fdn, Seoul, South Korea
[3] Samkwang Med Labs, Seoul, South Korea
[4] U2 Clin Labs, Seoul, South Korea
[5] Green Cross Labs, Yongin, South Korea
[6] Orebro Univ, World Hlth Org Collaborating Ctr Gonorrhoea & Oth, Orebro, Sweden
基金
美国国家卫生研究院;
关键词
HIGH-LEVEL RESISTANCE; ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANT; DECREASED SUSCEPTIBILITY; SPECTRUM CEPHALOSPORINS; UNTREATABLE GONORRHEA; MOLECULAR TESTS; CEFTRIAXONE; STRAIN; SURVEILLANCE;
D O I
10.3201/eid2503.181503
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In South Korea, surveillance of antimicrobial drug resistance in Neisseria gonorrhoeae is extremely limited. We describe the emergence and subsequent national spread of N. gonorrhoeae strains with mosaic penA alleles associated with decreased susceptibility and resistance to extended-spectrum cephalosporins. From 2012 through 2017, the proportion of mosaic penA alleles in gonococcal-positive nucleic acid amplification test (NAAT) specimens across South Korea increased from 1.1% to 23.9%. Gonococcal strains with mosaic penA alleles emerged in the international hubs of Seoul in Gyeonggi Province and Busan in South Gyeongsang Province and subsequently spread across South Korea. Most common was mosaic penA-10.001 (n = 572 isolates; 94.7%), which is associated with cefixime resistance. We also identified mosaic penA-34.001 and penA-60.001, both of which are associated with multidrug-resistant gonococcal strains and spread of cefixime and ceftriaxone resistance. Implementation of molecular resistance prediction from N. gonorrhoeae-positive nucleic acid amplification test specimens is imperative in South Korea and internationally.
引用
收藏
页码:416 / 424
页数:9
相关论文
共 50 条
[1]  
[Anonymous], 2011, JPN J SEX TRANSM S1, V22, P52
[2]  
[Anonymous], 2012, Regional Innovation Scoreboard 2012, P1, DOI DOI 10.2833/10759
[3]   2012 European guideline on the diagnosis and treatment of gonorrhoea in adults [J].
Bignell, C. ;
Unemo, M. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2013, 24 (02) :85-92
[4]   The Emerging Threat of Untreatable Gonococcal Infection [J].
Bolan, Gail A. ;
Sparling, P. Frederick ;
Wasserheit, Judith N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) :485-487
[5]   Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain [J].
Camara, Jordi ;
Serra, Judit ;
Ayats, Josefina ;
Bastida, Teresa ;
Carnicer-Pont, Dolors ;
Andreu, Antonia ;
Ardanuy, Carmen .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (08) :1858-1860
[6]  
Centers for Disease Control and Prevention (CDC), 2012, CEPH RES NEISS GON P, P1
[7]  
Chisholm SA, 2013, EUROSURVEILLANCE, V18, P14
[8]   New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan [J].
Deguchi, Takashi ;
Yasuda, Mitsuru ;
Hatazaki, Kyoko ;
Kameyama, Koji ;
Horie, Kengo ;
Kato, Taku ;
Mizutani, Kohsuke ;
Seike, Kensaku ;
Tsuchiya, Tomohiro ;
Yokoi, Shigeaki ;
Nakano, Masahiro ;
Yoh, Mutsumasa .
EMERGING INFECTIOUS DISEASES, 2016, 22 (01) :142-144
[9]  
Demczuk W, 2017, J CLIN MICROBIOL, V55, P1454, DOI [10.1128/jcm.00100-17, 10.1128/JCM.00100-17]
[10]   Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae [J].
Dona, Valentina ;
Low, Nicola ;
Golparian, Daniel ;
Unemo, Magnus .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (09) :845-859